Signs and symptoms in the child with suspected cancer - PowerPoint PPT Presentation

1 / 83
About This Presentation
Title:

Signs and symptoms in the child with suspected cancer

Description:

1 - 2% of total incidence of cancers. every year 130- 140 children 16y per million are diagnosed with ... Previous cat scratches, rodent bites, tick bites ... – PowerPoint PPT presentation

Number of Views:668
Avg rating:3.0/5.0
Slides: 84
Provided by: amb1
Category:

less

Transcript and Presenter's Notes

Title: Signs and symptoms in the child with suspected cancer


1
Signs and symptoms in the child
with suspected cancer
  • Maryna Krawczuk - Rybak
  • Department of Pediatric Oncology

2
Incidence
  • 1 - 2 of total incidence of cancers
  • every year 130- 140 children lt16y per million are
    diagnosed with childhood cancer
  • survival probability 70 -80
  • the incidence within the first 5 years of life is
    twice as high as from 6 to 15 years of age
  • Highest incidence in Nigeria, Los Angeles
    (white), Brasil (San
    Paulo), New Zealand, Sweden, Australia
    lowest Fiji, India, Kuwait, China
    (Taipei)

3
Distribution of cancer in children lt15 years of
age
  • ALL - 23.3
  • CNS tumors -20.7
  • Neuroblastoma - 7.3
  • Non-Hodgkin lymphoma - 6.3
  • Wilms tumor - 6.1
  • Hodgkin lymphoma - 5.0
  • Rhabdomyosarcoma - 3.4
  • Retinoblastoma - 2.9
  • osteosarcoma - 2.6
  • Ewings sarcoma - 2.1
  • other - 16.4

4
Hereditary component of pediatric malignancies
  • Tumor type Approximate

  • hereditary component ()
  • Optic gliomas 45
  • Retinoblastoma 40
  • Pheochromocytoma 25
  • Wilms tumor 3 5
  • CNS neoplasms 1 3
  • Leukemia 2.5 - 5

5
Differences between children and adults cancer

  • children
    adults
  • Primary location tissues
    organs
  • Histopatology non-epithelial gt90
    epithelial gt80
  • mesenchymal
    or
  • embryonal
    origin
  • Staging 80 disseminate
    local or regional
  • Screening neuroblastoma
    mammography

  • (catecholamines,usg) colonoscopy

  • cytology
  • Response drug and radio-
    less sensive
  • on treatment sensive
  • Prognosis 70 80
    40-50
  • curable
    curable

6
Dependence of age
  • 1 year - neuroblastoma,
    retinoblastoma,
  • hepatoblastoma,
    nephroblastoma
  • 2 5 y -ALL, CNS tumors,
  • Adolescence -Hodgkin lymphoma, osteosarcoma,
    sarcoma
    Ewing,
  • soft tissue sarcoma
  • Infancy and puberty gonadal tumors (boys)
  • Puberty- gonadal tumors (girls)

7
Dependence of age
  • gt80 neuroblastoma - in the first 3 y
  • 80 nephroblastoma - in the first 5 y
  • 70 bone tumors - in the age 10 15 y

8
Dependence of sex
  • More often in male 43
  • More often in male lymphomas, leukemias, CNS
    tumors, neuroblastoma, osteosarcoma, RMS
  • The same proportion nephroblastoma,
    retinoblastoma
  • More often in female germ cell tumors
    (adolescent), thyroid cancer, adrenal
    cancer

9
Common chief complaints given by parents
that suggest a
pediatric cancer
  • Chief complaints
  • Suggest cancer
  • Chronic drainage from ear
  • Recurrent fever with bone pain
  • Morning headache with vomiting
  • Lump in neck that does not respond to antibiotics
  • White dot in eye
  • Proptosis
  • RMS, LCH
  • Ewings sarcoma, leukemia
  • Brain tumor
  • Hodgkin lymphoma, NHL
  • Retinoblastoma
  • Leukemia, neuroblastoma histiocytosis, RMS

10
  • Swollen face and neck
  • Mass in abdomen
  • Paleness and fatigue
  • Limping
  • Bone pain
  • Bleeding from vagina
  • Weight loss
  • NHL, leukemia
  • Wilms tumor, neuroblastoma, NHL,
    hepatoblastoma/ hepatoma
  • Leukemia, lymphoma
  • Osteosarcoma, bone tumors, leukemia
  • Leukemia, Ewings sarcoma, NBL
  • Yolk sac tumor, RMS
  • Hodgkins lymphoma

11
Presenting signs and symptoms of some common
pediatric cancers and their differential
diagnosis
12
(No Transcript)
13
Lymphadenopathy
  • Transient proliferative response to local or
    generalized infection
  • Sign of malignancy

14
(No Transcript)
15
History
  • Duration of lymphadenopathy
  • Previous cat scratches, rodent bites, tick bites
  • Previous tonsillitis, skin lesions, infections
    in the lymphatic region drained
  • Significant weight loss
  • Night sweats
  • Fever

16
Location size
  • Tonsillar and inguinal lymph nodes secondary to
    localized infection
  • Supraclavicular, infraclavicular, axillary
    serious nature -left supraclavicular node
    gt malignant disease arising in the abdomen
    (lymphoma, RMS) and spreading via the thoracic
    duct
    -right
    supraclavicular node gt thoracic lesions (this
    node drains the superior areas of the lungs and
    mediastinum)
  • Nodes gt2.5 cm - pathologic

17
Character
  • Nodes
  • -firm, rubbery, matted -gt malignant
  • -warm, tender, fluctuant -gtinfection
  • -localized vs. generalized

18
Causes of lymphadenopathy
  • Infection

    -bacterial ( skin infection, staphylococcus,
    streptococcus, septicemia, tuberculosis,
    brucellosis)
    -viral ( mononucleosis, cytomegalovirus,
    rubella, varicella, HIV, adenovirus, herpes
    simplex, cat- scratch disease)

    -protozoal ( toxoplasmosis, trypanosomiasis)
    -spirochetal (syphilis,
    rat-bite-fever)
    -fungal (histoplasmosis,
    dermatophytosis, coccidioidomycosis)

    -Kawasakis disease
    -

19
  • Connective tissue disorders
    -rheumatoid
    arthritis
    -systemic lupus
    erythromatosus
  • Storage disease
    -
    Niemann- Pick disease
    - cystinosis
  • Granulomatous disease
    -sarcoidosis

    -chronic granulomatous
    disease

20
  • Lymphoproliferative disorders
    -autoimmune
    lymphoproliferative syndrome
    -angioimmunoblastic lymphadenopathy with
    dysproteinemia
    -X-linked
    lymphoproliferative syndrome
    -Castelmans disease
  • Neoplastic diseases
    -lymphoma

    -leukemia

    -metastases from solid
    tumors
    -histiocytoses

21
Investigations
  • Erythrocyte sedimentation, leukocytosis, CRP
  • Serologic tests (toxo, CMV, Epstein-Barr virus,
    HIV)
  • Chest radiograph, CT scan
  • Abdominal sonogram (or CT)
  • Lymph node biopsy
  • Bone marrow examination

22
Headaches
  • Complaints of repeated headaches signs of
    increased intracranial pressure brain tumor
  • In supratentorial tumors
    vomiting occured
    in 46
    headaches in 43
  • In infratentorial tumors
  • coordination difficulties - 60
  • vomiting 76
  • headaches 56

23
  • The best method of screening for brain tumor in
    patient with headaches is a careful neurologic
    examination, because approximately 95 of
    children with headache had abnormal neurologic
    findings in clinical examination!
  • Good clinical history
    -
    duration of symptoms and their location

    - timing, severity precipitating events
  • - mode of onset

24
  • Following symptoms suggest a brain tumor
  • Recurrent morning headaches
  • Headaches that awaken the child
  • Intense and incapacitating headaches
  • Changes in the quality, frequency and pattern of
    the headaches

25
Condition suggesting the need for CT
in children
with headaches
  • Presence or onset of neurologic abnormality
  • Ocular findings such as papilledema, decreased
    visual acuity, or loss of vision
  • Vomiting that is persistent, increasing in
    frequency, or preceded by recurrent headaches
  • Change in character of headaches, such as
    increased severity and frequency
  • Recurrent morning headaches or headaches that
    repeatedly awaken child from sleep
  • Short stature or deceleration of linear growth

26
  • Diabetes insipidus
  • Age of 3 years or less
  • Neurofibromatosis
  • Cured of ALL with irradiation of CNS as a part of
    initial treatment

27
Bone and joint pain
  • Is most common in children with
  • Ewings sarcoma 90 (intermittent at first gt
    increases in severity with time
  • Osteogenic sarcoma in 80
  • The time between the onset of symptoms and
    the diagnosis can be as long as 8 to 12 months

28
(No Transcript)
29
  • Arthralgias or bone pain may be prominent
    presenting features of acute lymphoblastic
    leukemia - in 27 33.
    Can
    be mistaken for various rheumatic disease!
  • Persistent bone or joint pain, especially if
    associated with swelling, mass, limitation of
    motion -
    made a radiograph!

30
Abdominal masses
  • Is the most common presenting finding of
    malignant solid tumors in children
  • In newborn/ infant - Wilms tumor or
    neuroblastoma
  • In older children is more likely to be
    secondary to leukemic or lymphomatous involvement
    of the liver or spleen
  • Kidney abnomalities
  • Faeces mass

31
(No Transcript)
32
  • Abdominal examination is frequently not easy gt
    the child has to be
    relaxed before palpating the abdomen
  • Radiological examination radiograph,
    ultrasonograph, CT
  • Urianalysis
  • Stool specimen
  • Tumor markers

33
Mediastinal masses
  • Benign and malignant tumors
  • Anterior mediastinum lymphomas, masses of
    thymic origin, teratomas, angiomas, lipomas,
    thyroid tumors
  • Middle mediastinum lymphomas, metastatic or
    infection-related lesions involving lymph nodes,
    pericardial cysts, bronchogenic cysts, esophageal
    lesions, hernias through the foramen Morgani
  • Posterior mediastinum neurogenic tumors and
    cysts (neuroblastoma, ganglioneuroblastoma,
    neurilemomas, ganglioneuromas, pheochromocytomas,
    thoracic meningocele, Ewings sarcomas,
    lymphoma, RMS

34
(No Transcript)
35
  • Patients may be asymptomatic or may present with
    symptoms secondary to compression or erosion of
    adjacent organs such as respiratory tract
    e.g. cough, stridor, hemoptysis
  • Mass is discovered during rutine chest
    radiographs
  • CT, ultrasound, MRI
  • Histologic examination

36
Pancytopenia and leukocytosis
  • Anemia, leukopenia, thrombocytopenia occur
    alone or in combination as a common presenting
    sign in acute leukemia

    - 50 present hemoglobin
    concentration lt 7.5 g/L - 70 -
    platelet counts lt 150.000/mm3
    - 30 - WBC lt 5.000/mm3
  • Lymphomas, NBL, Ewings sarcoma, RMS

37
Leukocytosis
  • Acute leukemia
    -
    gt40.000/mm3 in 45 children with ALL
    gt 100.000/mm3 - in 10
    children with ALL

    in 20 with AML
  • Nonmalignant causes
    -
    infections (staphylococcal, pneumococcal,
    Haemophilus, meningococcus, Salmonella)

    - lymphoid leukemoid reaction infectious
    lymphocytosis, mumps, varicella, adenovirus,
    cytomegalovirus, pertussis infections

    - eosinophilia parasitic
    infections, visceral larval migrans,
    hypereosinophilic syndrome, allergy

38
Central nervous system malignancies
39
Epidemiology
  • Commonest malignant solid tumors in childhood
  • 20 of cancers in age lt 15 years
  • Annually 20 26/ 1 million children below the
    age of 16 years
  • Age stratified incidence is
    lt1year
    - 27/ 1 million

    1 4 - 31/ 1
    million
    5 9
    - 27/ 1 million
    10 14
    - 20/ 1 million
  • Slightly higher frequency in boys 1.251
    (especially for medulloblastoma and germinoma)

40
Etiology and pathogenesis
  • Association between primary CNS tumors and
    following conditions/ genetic disorders

    1. Neurofibromatosis
    (NF) type 1 and 2
    2. Tuberous sclerosis
    3. Von
    Hippel- Lindau syndrome
    4. Gordlins, Cowdens,
    Turcots syndromes
    5. Li-Fraumeni syndrome (mutation of
    suppressor oncogene p53)
  • Deletion of chromosome 17 or 20 (medulloblastoma)
  • Exposition of the brain to ionizing radiation
    i.e. after cranial radiotherapy in leukemia

41
Pathology
  • Supratentorial lesions (30 40)
    1.
    Cerebral hemisphere ( astrocytoma, ependymoma,
    glioblastoma, meningioma)
    2. Sella or
    chiasm ( craniopharyngioma, pituitary adenoma,
    optic nerve glioma)
  • Infratentorial lesions (60 70)
    1. Cerebellum
    (medulloblastoma, astrocytoma, meningioma)

    2. Brain stem (
    astrocytoma, ependymoma, glioblastoma)

42
Classification
  • Based on histogenesis and predominance of cell
    type
  • Degree of malignancy is defined by grading system
    e.i. WHO grade based on cellular morphology,
    mitotic index, anaplasia and necrosis

    grades I and II represent benign tumors
    grades III and IV -
    malignant tumors

43
Clinical presentation
  • Depends on
    - age

    -anatomical site
    -tumor type
  • -raised intracranial pressure (ICP)
    -localizing neurological deficits

44
Signs of increased IPC
  • Direct tumor infiltration
  • Compression of normal structures
  • Secondary to obstruction of the cerebrospinal
    fluid (CSF)

45
  • Older children

    -inilially behavioural changes and declining
    school performance prior to development of the
    more classical features of headache, nausea and
    vomiting , headaches start as generalized and
    intermittent gt increase
    in both intensity and frequency with time -
    the child may awake with headache at night,
    with the pain generally being worse in the
    morning and improving during the day with an
    upright posture
    -School-age children complain of visual
    disturbances

46
  • Infants and younger children
    plasticity of the
    developing skull and inability to communicate
    symptoms gt
    -infant may be irratable, with
    failure to thrive, associated with anorexia and
    vomiting
    -regression of developmental
    milestones
    -increase head circumference with widened
    sutures and a tense anterior fontanelle

    sun-setting sign

47
Symptoms and signs according to anatomical site
of CNS tumors
  • Supratentorial (30-40)

    Cerebral hemisphere- hemiparesis, spasticity,
    seizures (focal or generalized)

    -
    para/suprasellar endocrinopathy (growth
    failure, diabetes insipidus, pubertal
    abnormality)

    - hypothalamus diencephalic syndrome
    (infants), developmental and behavioural
    abnormalities
    - optic
    pathway visual field, acuity, color vision
    deficits, optic atrophy, nystagmus, head tilt

    - pineal - Parinauds
    syndrome, sleep abnormalities
    - thalamus, basal ganglia pain,
    sensory loss, memory disturbances
  • - intraventicular

    - meningeal

48
  • Infratentorial (60 70)

    - posterior fossa ataxia, nystagmus,
    dysmetria (presents as clumsiness or worse
    handwriting)
    - brainstem multiple
    cranial nerve palsies, hemiparesis, spasticity,
    mood changes
  • Spinal (2 5)

    - primary intramedullary pain (local
    back and root pain), motor and sensory
    disturbance
    -
    spinal metastases scoliosis, sphincter (bowel,
    bladder) disturbances, reflex changes

49
Diagnostic evaluation
  • Magnetic resonance and computed tomography
    basic imaging techniques for brain tumors
  • Positron emission tomography help to
    distinguish tumors or lesions with a volume
    greater than 1 cm3
  • Conventional radiography of the skull bone
    structure, separating off sutures ( due to ICP),
    calcification within the brain
  • Special methods (for special indications)

    - brain scintigraphy

    - angiography

    -ultrasonography


    -myelography

50
Additional diagnosis
  • Cerebral fluid analysis ( to determine spread of
    the tumor to the spinal fluid)
  • Electroencephalography
  • Stereotactic biopsy

51
Therapy
  • Neurosurgery for maximum tumor removal and low
    morbidity depending on the location and extent of
    the tumor

    -often preoperative relief of intracranial
    pressure by ventriculoperitoneal or
    ventriculoarterial shunt
    - preoperative reduction of
    tumor edema by corticosteroids

    - in patients with seizures -
    anticonvulsive therapy

52
  • Radiotherapy extension and volume of
    irradiation depend on the biology and histology
    of the tumor, age of the child and combination
    with chemotherapy and neurosurgery

    - irradiation in children lt 3
    years of life only in special cases
  • Chemotherapy depends on tumor type, location
    and age -efficacy and penetration depend on
    vascularization of the tumor

53
MR spectra and MR images of medulloblastoma
54
8-year-old girl with juvenile pilocytic
astrocytoma
55
2-year-old boy with atypical teratoid-rhabdoid
tumor
56
  • Neuroblastoma

57
  • Malignant, embryonal tumor derived from precursor
    cells of sympathetic ganglia and adrenal medulla
  • Other types of tumors derived from sympathetic
    nervous system

    -ganglioneuroblastoma
    -ganglioneuroma

    -pheochromocytoma
  • Possibility to spontaneous regression and
    differentiation to benign tumor in infants less
    1 year of age

    extremely malignant in older children

58
Epidemiology
  • 8 of all neoplasms in children
  • Most frequent malignant neoplasm in infants
  • Mean age at diagnosis 2 5 years

59
Pathology
  • Two distinct entities
    1.
    possibility of spontaneous regression (apoptosis
    or differentiation into ganglioneuroblastoma)
    2.
    chemosensitive, chemocurable
    3. chemoresistant malignancies

60
Molecular cytogenetics
  • MYCN oncogene amplification.

    MYCN is located on chromosome 2p.


    Independent prognostic factor
    in
    stage III EFS for patients with a single copy
    is 80
    for those with amplification MYCN 20
  • DNA ploidy hyperploidy good prognosis
  • Nerve growth factor receptor ligands for high
    affinity tyrosine kinase receptors TRKA, TRKB,
    TRKC
    -TRKA expression
    is associated with MYCN single copy, low stage
    and good prognosis

    - TRKA (-) MYCN amplification very poor
    survival
  • Structural and numerical abnormalities of
    chromosome 1

61
Clinical manifestation
  • Occurence in any area with sympathetic nervous
    system

    Primary location

    -abdomen
    65
    -adrenal medulla
    or sympathetic ganglia 46
    -posterior
    mediastinum 15
    -pelvic
    4
    -head and neck
    3
    -others
    8

62
2-year-old-girl with abdominal neuroblastoma
63
Horners syndrome
64
Cancer cachexia
65
Common symptoms
  • Weight loss
  • Fever
  • Abdominal disturbances
  • Irratability
  • pain of bones and joints
  • Child not stand up, not walk
  • Pallor
  • Lassitude

66
Symptoms associated
with catecholamine
production
  • Paroxysmal attacks of sweating, flushing, pallor
  • Headache
  • Hypertension
  • Palpitation

67
Paraneoplastic syndromes
  • VIP syndrome untreatable diarrhea,with low level
    of potassium
  • Opsoclonus
  • Anemia, trombocytopenia, leukopenia( in bone
    marrow infiltration or massive hemorrhage)

68
Local symptoms
  • Abdomen

    -intra-abdominal tumor retroperitoneal
    locationparavertebral and presacral
    -neurological dysfunction -abdominal distension
  • Liver

    -hepatomegaly
  • Chest, posterior mediastinum, vertebrae
    -compression of
    trachea gt coughing, dyspnea
    -infiltration in vertebral foramina
    gt dumbbell tumor
    -compression of nerves gtdisturbances of gait,
    muscle weakness, parasthesia, bladder
    dysfunction, constipation

69
  • Eyes

    -periorbital edema, swelling, yellow- brown
    ecchymoses
    -proptosis and
    exophthalmos, strabismus, opsoclonus

    -papillary edema, bleeding of the retina,
    atrophy of the optic nerve
  • Neck

    -cervical lymphadenopathy

    -supraclavicular tumor
    -Horner syndrome
    enophthalmos, miosis, ptosis, anhydrosis

70
  • Skin

    -subcutaneous
    nodules of blue color gt reddish gt white
    owing to vasoconstriction from release of
    catecholamines after palpation

    - nodules are mainly observed in
    neonates or infants with disseminated NBL
  • Bone

    -pain

    involvement mainly in the skull
    and long bones
    - in X-rays lytic defects
    with irregular margins and periosteal reaction
  • Bone marrow

    -trombocytopenia, anemia

71
Metastases
  • Lymphatic and/or hematogenous spread
  • Often initially present in children
    (40 50 children lt
    1 year and 70 children gt 1 year)
  • Metastatic spread mostly in bone marrow, bone,
    liver, skin

72
International Staging System for NBL(INSS)
  • 1 - localized tumor with complete
    excision,lymph nodes negative
  • 2a - localized tumor without incomplete gross
    excision, representative, ipsilateral nonadherent
    lymph nodes negative for tumor microscopically
  • 2b ipsilateral nonadherent lymph nodes positive
    for tumor. Enlarged contralateral lymph nodes
    negative microscopically
  • 3 unresectable unilateral tumor infiltrating
    across the midline,with or without regional lymph
    node involvement or localized unilateral tumor
    with contralateral regional lymph node
    involvement or midline tumor with bilateral
    extension by infiltration or by lymph node
    involvement
  • 4 any primary tumor with dissemination to
    distant lymph nodes, bone, bone marrow, liver,
    skin or other organs (except as defined for stage
    4S
  • 4s localized primary tumor (as defined for
    stages 1, 2a, 2b) with dissemination limited to
    skin, liver or bone marrow limited to infants
    aged less than 1 year)

73
(No Transcript)
74
Laboratory findings
  • Tumor markers

    -catecholamines

    vanillylmandelic acid (VMA), homovanillic acid
    (HVA) dopamine in urine/ plasma

    adrenaline, noradrenaline

    -neuron-specific enolase (glycolitic enzyme of
    brain and neuroendocrine tissues) -NSE
  • Ferritin
  • Lactate dehydrogenease (LDH)
  • Bone marrow (aspiration and biopsy)

75
Locoregional involvement
  • Computed tomography scan and/or
  • Ultrasound and/or
  • magnetic resonance imaging gt localize the mass,
    provide measurements, give anatomical information
    about intra- and extraperitoneal structures,
    differentiate cystic from solid tumors, define
    the extent of a primary tumor and its
    relationship with other structures, detect small
    calcification

76
Evaluation of metastases
  • Bone marrow metastases bone marrow aspiration
    and trephine biopsy
  • Skeletal metastases - X-ray, Tc-99 scintigraphy,
  • mIBG scintigraphy demonstrates primary, residual
    tumor masses,diffuse bone marrow infiltration,
    skeletal, lymph node and soft tissue metastases
  • FDG-PET scanning

77
Infant with neuroblastoma(stage 4S)
78
(No Transcript)
79
Therapy
  • Depends on age, stage, localization and
    molecular features at diagnosis
  • Surgery
  • Chemotherapy
  • Radiotherapy
  • Target radiotherapy (I-131-mIBG)
  • Differentiation therapy(retinoids 13-cis and
    all-trans)
  • Immunotherapy anti-GD2 antibodies

80
Prognosis
  • Depends on

    -age (favorable if less than 18 months of age at
    diagnosis), -stage and localization (favorable in
    primary NBL of thorax, presacral and cervical)

    -involvement of lymph nodes (poor prognosis)
  • Low-risk group - 90 long-term survival
  • Intermediate and high-risk groups
    -response to initial
    treatment 60-70 of children with complete or
    partial remission
    -after consolidation therapy
    (high-dose chemotherapy autologous stem cell
    support) EFS after 3 years is 40-60

81
CT image with large abdominal neuroblastoma
82
Neuroblastoma FDG-PET scans
83
123-MIBG scintscan
Write a Comment
User Comments (0)
About PowerShow.com